Treace Medical Concepts, Inc. (TMCI)
NASDAQ: TMCI · Real-Time Price · USD
3.510
-0.180 (-4.88%)
At close: Jun 5, 2026, 4:00 PM EDT
3.700
+0.190 (5.41%)
After-hours: Jun 5, 2026, 7:17 PM EDT

Treace Medical Concepts Revenue

Treace Medical Concepts had revenue of $47.20M in the quarter ending March 31, 2026, a decrease of -10.22%. This brings the company's revenue in the last twelve months to $207.32M, down -1.66% year-over-year. In the year 2025, Treace Medical Concepts had annual revenue of $212.69M with 1.59% growth.

Revenue (ttm)
$207.32M
Revenue Growth
-1.66%
P/S Ratio
1.10
Revenue / Employee
$460,707
Employees
450
Market Cap
227.70M

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 2025212.69M3.33M1.59%
Dec 31, 2024209.36M22.24M11.89%
Dec 31, 2023187.12M45.28M31.92%
Dec 31, 2022141.84M47.42M50.22%
Dec 31, 202194.42M37.05M64.59%
Dec 31, 202057.37M17.95M45.54%
Dec 31, 201939.42M--

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
Quanterix144.98M
InfuSystem Holdings142.40M
RxSight127.48M
Sight Sciences79.55M
Electromed71.75M
908 Devices57.80M
Apyx Medical55.90M
TriSalus Life Sciences44.88M
Revenue Rankings